Regeneron Pharmaceuticals Breaks Channel Resistance

By | November 19, 2014

I’ve been following the movement of Regeneron Pharmaceuticals (REGN) shares within a series of price channels for some time, and this week they are breaking above the most recent level of resistance. If they were to hold this level and begin another measured move, the target projection is in the $452.00 area.

19. REGN  chart

Leave a Reply